Mitochondrial Delivery of Bongkrekic Acid Using a MITO-Porter Prevents the Induction of Apoptosis in Human HeLa Cells
- 1 March 2013
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 102 (3) , 1008-1015
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Mitochondria and cell death: outer membrane permeabilization and beyondNature Reviews Molecular Cell Biology, 2010
- Mitochondrial drug delivery and mitochondrial disease therapy – An approach to liposome-based delivery targeted to mitochondriaMitochondrion, 2007
- Cellular Uptake of Arginine-Rich Peptides: Roles for Macropinocytosis and Actin RearrangementMolecular Therapy, 2004
- Design and Combinatorial Synthesisof N-Acyl Iminodiacetic Acids as BongkrekicAcid Analogues for the Inhibition of Adenine Nucleotide TranslocaseSynthesis, 2003
- Arginine-rich PeptidesJournal of Biological Chemistry, 2001
- Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosisFEBS Letters, 1996
- Mitochondrial control of nuclear apoptosis.Journal of Experimental Medicine, 1996
- Total synthesis of bongkrekic acidJournal of the American Chemical Society, 1984
- Inhibitors of the adenine nucleotide translocasePharmacology & Therapeutics, 1979
- On the inhibition of the adenine nucleotide translocation by bongkrekic acidBiochemical and Biophysical Research Communications, 1970